Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Martina Lehnert"'
Publikováno v:
Therapeutische Umschau. 67:271-276
Erythropoese-stimulierende Proteine (ESPs) sind für die Behandlung bei Patienten mit Chemotherapie-induzierter Anämie zugelassen und führen bei etwa 60 – 70 % der Patienten zu einem deutlichen Anstieg der Hämoglobinwerte und zu einer signifikan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e8018d1fe150254b213de768367411f
https://doi.org/10.1024/0040-5930/a000048
https://doi.org/10.1024/0040-5930/a000048
Autor:
Fritz Wrba, Beata Herberger, Martin Filipits, Anita Brandstetter, Martina Lehnert, Robert Pirker, Thomas Gruenberger, Birgit Gruenberger, Harald Puhalla, Sabine Novak
Publikováno v:
Clinical Cancer Research. 13:4795-4799
Purpose: The mammalian target of rapamycin (mTOR) is a protein kinase that plays a key role in cellular growth and homeostasis. Because its regulation is frequently altered in tumors, mTOR is currently under investigation as a potential target for an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c858f5beef2e2fb6af6997119b4c64dc
https://doi.org/10.1158/1078-0432.ccr-07-0738
https://doi.org/10.1158/1078-0432.ccr-07-0738
Publikováno v:
Lung Cancer. 55:89-94
Anemia occurs frequently in patients with lung cancer receiving chemotherapy and has a negative impact on quality of life (QoL). Erythropoietic proteins effectively increase hemoglobin (Hb) levels, reduce transfusion requirements and improve QoL in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::490ea18f89159a5c0bbf803e60fb4315
https://doi.org/10.1016/j.lungcan.2006.09.020
https://doi.org/10.1016/j.lungcan.2006.09.020
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 67(5)
Erythropoiesis stimulating proteins are approved for chemotherapy-induced anemia. Treatment with ESPs results in an increase in hemoglobin in 60 - 70 % of patients and in a significant reduction in transfusion need. A marked increase in hemoglobin le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::274128b5efddb587497e6367a6c1b80d
https://pubmed.ncbi.nlm.nih.gov/20509125
https://pubmed.ncbi.nlm.nih.gov/20509125
Publikováno v:
OncoTargets and Therapy.
Martina Lehnert, Heinz Ludwig, Niklas Zojer 1st Department of Medicine, Center for Oncology and Hematology, Wilhelminenspital, Vienna, AustriaAbstract: The development of radiolabeled antibodies against CD20 has facilitated targeted treatment of foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::55b521a4640418e355d48d284ddc6561
https://www.dovepress.com/update-on-the-rational-use-of-90y-ibritumomab-tiuxetan-in-the-treatmen-peer-reviewed-article-OTT
https://www.dovepress.com/update-on-the-rational-use-of-90y-ibritumomab-tiuxetan-in-the-treatmen-peer-reviewed-article-OTT
Autor:
Margaretha, Rudas, Martina, Lehnert, Anh, Huynh, Raimund, Jakesz, Christian, Singer, Sigurd, Lax, Walter, Schippinger, Otto, Dietze, Richard, Greil, Wolfgang, Stiglbauer, Werner, Kwasny, Renate, Grill, Michael, Stierer, Michael F X, Gnant, Martin, Filipits, P, Riss
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 14(6)
Purpose: The objective of our study was to determine the clinical relevance of cyclin D1 expression in hormone receptor–positive breast cancer patients who were treated with tamoxifen-based therapy. Experimental Design: We assessed expression of cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::174b88cf972e87d9b48fe879a24eedc4
https://pubmed.ncbi.nlm.nih.gov/18347178
https://pubmed.ncbi.nlm.nih.gov/18347178
Publikováno v:
Lung Cancer. 49:S340-S341
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f20483cd72e192946a774b39de3b0d0
https://doi.org/10.1016/s0169-5002(05)81333-9
https://doi.org/10.1016/s0169-5002(05)81333-9
Publikováno v:
OncoTargets and Therapy, Vol 2009, Iss default, Pp 199-208 (2009)
Martina Lehnert, Heinz Ludwig, Niklas Zojer 1st Department of Medicine, Center for Oncology and Hematology, Wilhelminenspital, Vienna, AustriaAbstract: The development of radiolabeled antibodies against CD20 has facilitated targeted treatment of foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::126b70bb6be5e3bb93be21bd76bf5d60
https://doi.org/10.2147/ott.s3975
https://doi.org/10.2147/ott.s3975